LLY
1,076.96
+0.06%↑
JNJ
207.49
-0.14%↓
ABBV
230.16
+0.01%↑
UNH
331.59
+1.17%↑
AZN
92.89
+0.42%↑
LLY
1,076.96
+0.06%↑
JNJ
207.49
-0.14%↓
ABBV
230.16
+0.01%↑
UNH
331.59
+1.17%↑
AZN
92.89
+0.42%↑
LLY
1,076.96
+0.06%↑
JNJ
207.49
-0.14%↓
ABBV
230.16
+0.01%↑
UNH
331.59
+1.17%↑
AZN
92.89
+0.42%↑
LLY
1,076.96
+0.06%↑
JNJ
207.49
-0.14%↓
ABBV
230.16
+0.01%↑
UNH
331.59
+1.17%↑
AZN
92.89
+0.42%↑
LLY
1,076.96
+0.06%↑
JNJ
207.49
-0.14%↓
ABBV
230.16
+0.01%↑
UNH
331.59
+1.17%↑
AZN
92.89
+0.42%↑
24h
Praegune
Min
310.91
Max
312.34
Sissetulek | 31M 125M |
|---|---|
Müük | 97M 1.4B |
Kasumimarginaal | 8.84 |
Soovitused | Tugev "osta" hinnang |
|---|---|
12 kuu keskmine prognoos | +27.3% upside |
Turukapital | 22B |
|---|---|
Eelmine avamishind | 311.13 |
Eelmine sulgemishind | 311.64 |
By Acuity
50%
50%
156 / 374 Pingereas Healthcare
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
17. nov 2025, 12:16 UTC
Zymeworks, Jazz Pharmaceuticals Shares Rise Following Positive Phase 3 Results for Cancer Treatment
DJ
Loe
12. mai 2025, 02:16 UTC
Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs
DJ
Loe
29. jaan 2025, 15:59 UTC
ImmunityBio Shares Rise After Collaboration, Supply Agreement With BeiGene
DJ
Loe
14. dets 2025, 08:30 UTC
Kymera Had a Big Week. This Secretive Hedge Fund Bought $172 Million of Its Stock. -- Barrons.com
DJ
Loe
6. nov 2025, 11:01 UTC
BeOne Medicines Sees FY25 Rev $5.1B-$5.3B >ONC
DJ
Loe
6. nov 2025, 11:01 UTC
BeOne Medicines 3Q Adj EPS $2.65 >ONC
DJ
Loe
6. nov 2025, 11:01 UTC
BeOne Medicines 3Q Rev $1.4B >ONC
DJ
Loe
6. nov 2025, 11:00 UTC
BeOne Medicines 3Q EPS $1.09 >ONC
DJ
Loe
6. aug 2025, 10:01 UTC
BeOne Medicines Narrows FY25 View To Rev $5.0B-$5.3B >ONC
DJ
Loe
6. aug 2025, 10:01 UTC
BeOne Medicines 2Q Rev $1.3B >ONC
DJ
Loe
6. aug 2025, 10:01 UTC
BeOne Medicines 2Q Adj EPS $2.25 >ONC
DJ
Loe
6. aug 2025, 10:00 UTC
BeOne Medicines 2Q EPS 84c >ONC
DJ
Loe
9. juuli 2025, 09:17 UTC
Stocks to Watch Wednesday: Freeport-McMoRan, Glencore, Novo Nordisk -- WSJ
DJ
Loe
7. mai 2025, 10:07 UTC
BeiGene Maintains 2025 Expense Guidance of $4.1B to $4.4B >ONC
DJ
Loe
7. mai 2025, 10:06 UTC
BeiGene Backs 2025 Rev $4.9B-$5.3B >ONC
DJ
Loe
7. mai 2025, 10:05 UTC
BeiGene 1Q Net $1.27M >ONC
DJ
Loe
7. mai 2025, 10:04 UTC
BeiGene Says to Rename Company to BeOne Medicines >ONC
DJ
Loe
7. mai 2025, 10:02 UTC
BeiGene 1Q EPS $0.00 >ONC
DJ
Loe
7. mai 2025, 10:02 UTC
BeiGene 1Q Rev Increased 49% >ONC
DJ
Loe
7. mai 2025, 10:00 UTC
BeiGene 1Q Rev $1.12B >ONC
DJ
Loe
27. veebr 2025, 11:07 UTC
BeiGene Sees 2025 Rev $4.9B-$5.3B >ONC
DJ
Loe
27. veebr 2025, 11:06 UTC
BeiGene 4Q Global BRUKINSA Rev of $828M >ONC
DJ
Loe
27. veebr 2025, 11:06 UTC
BeiGene 4Q Loss/Shr 11c >ONC
DJ
Loe
27. veebr 2025, 11:06 UTC
BeiGene 4Q Rev $1.13B >ONC
DJ
Loe
Hinnamuutus
By TipRanks
12 kuu keskmine prognoos
Keskmine 397.66 USD 27.3%
Kõrge 424 USD
Madal 362 USD
Põhineb 13 Wall Streeti analüütiku instrumendi BeOne Medicines Ltd ADR 12 kuu hinnasihil - viimase 3 kuu andmed.
By TipRanks
Tugev "osta" hinnang
13 ratings
12
Osta
1
Hoia
0
Müü
Põhineb 13 analüütiku instrumendi BeOne Medicines Ltd ADR aktsia reitingul - viimase 3 kuu andmed.
By Acuity
Uudiste sentiment
Neutral
Volatiilsus
Alla keskmise
Uudismaht (RCV)
Alla keskmise
Müügi- ja halduskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Ärikasum
$